Alaunos Therapeutics TCRT
NASDAQ TCRT
$1.61 -0.10 (-5.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Alaunos Therapeutics (TCRT) Gains from Sales and Divestitures (2009 - 2023)

Updated

Alaunos Therapeutics (TCRT) reported Gains from Sales and Divestitures of $5,000 for Q4 2023, compared with -$7,000 a year earlier.

Analysis

Alaunos Therapeutics (TCRT) Gains from Sales and Divestitures (2009 - 2023) Analysis & Trends

For FY2023, Alaunos Therapeutics posted Gains from Sales and Divestitures of -$7,000.

  • By year, Gains from Sales and Divestitures came in at -$7,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Alaunos Therapeutics 4.16 Mn 357,198.54 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 5,000.00
Sep 30, 2023 -2,000.00
Dec 31, 2022 -7,000.00
Mar 31, 2014 641,000.00
Dec 31, 2013 -391,000.00
Sep 30, 2013 -251,000.00
Mar 31, 2013 57,000.00
Sep 30, 2012 -66,000.00
Jun 30, 2012 9,000.00
Mar 31, 2012 9,000.00
Sep 30, 2011 -9,000.00
Mar 31, 2011 9,000.00
Mar 31, 2010 9,000.00
Mar 31, 2009 9,000.00
API Access

Alaunos Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TCRT&period=max&api_key=YOUR_API_KEY